Q1 2025 Hologic Inc Earnings Call Transcript
Key Points
- Hologic Inc (HOLX) reported total revenue of $1.022 billion for the first quarter, in line with guidance and reflecting a 1% increase on a constant currency basis.
- Non-GAAP earnings per share were $1.03, at the high end of the guidance range, showing a 5% increase.
- The diagnostics division performed strongly, with revenue growing 5.2% and 9.1% organically, excluding COVID-related sales.
- The company has a robust pipeline with more than 20 assays on the Panther and Panther Fusion platforms, supporting future growth.
- Hologic Inc (HOLX) continues to leverage its strong cash flow from market-leading brands to drive innovation and acquisitions, such as the recent Gynesonics acquisition.
- Breast health revenue declined by 2.1% or 5.8% organically, primarily due to lower sales of capital equipment.
- The company lowered its full-year revenue guidance by $100 million due to factors including a stronger US dollar and softer breast health capital equipment sales.
- Hologic Inc (HOLX) faces potential policy-related revenue disruptions, such as the freeze on foreign aid affecting HIV testing partnerships.
- The skeletal business saw a significant revenue decrease of 37.4% due to delayed shipping of Horizon DXA units.
- The company anticipates tariffs on products manufactured in Mexico, which could impact gross margins.
Good afternoon and welcome to the Hologic's first quarter fiscal 2025 earnings conference call. My name is Lisa and I'm your operator for today's call. Today's conference is being recorded. All lines have been placed on mute.
I would now like to introduce Mike Watts, Corporate Vice President, Investor Relations, to begin the call. Please go ahead, sir.
Thank you, Lisa. Good afternoon and thank you for joining Hologic's first quarter fiscal 2025 earnings call. With me today is Steve MacMillan, the company's Chairman, President and Chief Executive Officer; Essex Mitchell, our Chief Operating Officer; and Karleen Oberton, our Chief Financial Officer.
Our first quarter press release is available now on the investors section of our website. We will also post our prepared remarks to our website shortly after we deliver them. And a replay of this call will be available on our website for the next 30 days.
Before we begin, we'd like to inform you that certain statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
